Therefore, we initiated this study to analyze the protein expression of ACE2, TMPRSS2, and FURIN on a panel of NSCLC patient tissue samples, taking into account neo-adjuvant therapies. The gene discussed is TMPRSS2; the disease is non-small cell lung carcinoma.